{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:59Z","timestamp":1792686299764,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajog.2024.06.040","type":"journal-article","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T13:56:15Z","timestamp":1719755775000},"page":"630.e1-630.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial"],"prefix":"10.1016","volume":"231","author":[{"given":"Charles E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juki","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Snabes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.06.040_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.06.040_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpobgyn.2018.06.001","article-title":"Risk for and consequences of endometriosis: a critical epidemiologic review","volume":"51","author":"Shafrir","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.06.040_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/humupd\/dmt016","article-title":"Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review","volume":"19","author":"Janssen","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2024.06.040_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/humupd\/dmq050","article-title":"Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications","volume":"17","author":"Stratton","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2024.06.040_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/0167482X.2015.1074173","article-title":"Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference","volume":"36","author":"Facchin","year":"2015","journal-title":"J\u00a0Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.06.040_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1783\/147118907781004831","article-title":"Endometriosis-associated dyspareunia: the impact on women's lives","volume":"33","author":"Denny","year":"2007","journal-title":"J\u00a0Fam Plann Reprod Health Care"},{"key":"10.1016\/j.ajog.2024.06.040_bib7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/humrep\/dey115","article-title":"Fatigue - a symptom in endometriosis","volume":"33","author":"Ramin-Wright","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.06.040_bib8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","article-title":"Rethinking mechanisms, diagnosis and management of endometriosis","volume":"15","author":"Chapron","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajog.2024.06.040_bib9","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.3390\/ijms20225615","article-title":"The pathogenesis of endometriosis: molecular and cell biology insights","volume":"20","author":"Lagana","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2024.06.040_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1933719113497292","article-title":"Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study","volume":"21","author":"Diamond","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2024.06.040_bib11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jc.2016-3845","article-title":"Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women","volume":"102","author":"Ng","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.06.040_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.06.040_bib13","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/AOG.0000000000002933","article-title":"Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Carr","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.040_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1056\/NEJMoa1904351","article-title":"Elagolix for heavy menstrual bleeding in women with uterine fibroids","volume":"382","author":"Schlaff","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.06.040_bib15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1177\/1933719118789509","article-title":"Development and validation of the endometriosis daily pain impact diary items to assess dysmenorrhea and nonmenstrual pelvic pain","volume":"25","author":"Wyrwich","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2024.06.040_bib16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis","volume":"382","author":"Zondervan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.06.040_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0000000000002675","article-title":"Long-term outcomes of elagolix in women with endometriosis: results from two extension studies","volume":"132","author":"Surrey","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.040_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.040_bib19","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.040_bib20","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(22)00622-5","article-title":"Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)","volume":"399","author":"Giudice","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.06.040_bib22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/1471-0528.15692","article-title":"Influence of race\/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta-analysis","volume":"126","author":"Bougie","year":"2019","journal-title":"BJOG"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824007312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824007312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T22:33:12Z","timestamp":1732141992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824007312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0002937824007312"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.06.040","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}